July 10, 2025

HHS Scraps Preventive Care Panel Meeting

HHS unexpectedly canceled a meeting of the U.S. Preventive Services Task Force, prompting fears it may be dismantled following similar moves by Secretary Robert F. Kennedy Jr. at other federal health agencies.

Conexiant

July 02, 2025

Body Fat Percentage Outranks BMI for Mortality

New research shows body fat percentage predicts long-term mortality more accurately than BMI, suggesting a need to revise how body composition is measured in clinical care.

Conexiant

June 30, 2025

Breakthrough Device Approvals Outpacing Data

Many FDA-authorized breakthrough therapeutic devices may lack robust clinical testing.

Conexiant

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

Weight Loss Drugs, Heavier Implications

New guidance positions GLP-1 and GLP-1/GIP therapies as frontline options for long-term weight management—with profound implications for cardiovascular outcomes, access equity, and chronic disease care.

Conexiant

June 26, 2025

Testosterone, Sleep Duration Linked to Psoriasis Risk

Low testosterone and insufficient sleep were both linked to higher odds of psoriasis in a U.S. population study, even after adjusting for age, BMI, and other factors.

Conexiant

June 26, 2025

Recalling Daily Events Improves Morning Memory

A behavioral task asking older adults to recall daily events before sleep was linked to better memory recognition the next morning, showing potential as a low-risk strategy to support cognitive health in aging and early Alzheimer’s disease.

Conexiant

June 25, 2025

Medical Oddities: Tomb Fungus, Cancer Hope?

Hot nights, healing skin, and ancient fungus: medicine’s weirdest wins this week.

Conexiant

June 25, 2025

Blood Marker May Predict Faster Brain Decline

A new study found that higher triglyceride-glucose index levels, a marker of insulin resistance, were linked to faster cognitive decline in early Alzheimer's, suggesting potential for improved risk assessment in clinical settings.

Conexiant